股票行情快报：迈得医疗（688310）10月31日主力资金净卖出186.77万元

Core Viewpoint - The stock of Maide Medical (688310) has shown a slight increase of 1.9% on October 31, 2025, closing at 19.33 yuan, with notable fluctuations in capital flow indicating mixed investor sentiment [1][2]. Financial Performance - For the first three quarters of 2025, Maide Medical reported a main revenue of 225 million yuan, a year-on-year increase of 2.31%, and a net profit attributable to shareholders of 8.84 million yuan, up 15.82% year-on-year [3]. - In Q3 2025, the company achieved a single-quarter main revenue of 83.64 million yuan, reflecting a significant year-on-year increase of 54.38%, and a net profit of 2.79 million yuan, which is a remarkable rise of 224.07% year-on-year [3]. Capital Flow Analysis - On October 31, 2025, the net outflow of main funds was 1.87 million yuan, accounting for 3.32% of the total transaction amount, while retail investors saw a net inflow of 664,600 yuan, representing 1.18% of the total transaction amount [1][2]. - Over the past five days, the stock has experienced fluctuations in capital flow, with significant net inflows and outflows from different investor categories [2]. Industry Comparison - Maide Medical's total market value stands at 3.213 billion yuan, which is below the industry average of 7.798 billion yuan, ranking 205th out of 269 in the specialized equipment industry [3]. - The company's price-to-earnings ratio (P/E) is 272.7, significantly higher than the industry average of 146.16, indicating a potential overvaluation compared to peers [3]. Company Overview - Maide Medical specializes in the research, production, sales, and service of medical consumables and intelligent equipment, integrating technology in medical device processes, automation, and software to provide comprehensive solutions for medical consumable manufacturers [3].